About The Medical Condition Evaluation Studies, FDA Phase 2
Find the definition of the medical term Evaluation Studies, FDA Phase 2. Evaluation Studies, FDA Phase 2 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Evaluation Studies, FDA Phase 2
| Evaluation Studies, FDA Phase 2 Medical Condition |
|---|
What's The Definition Of The Medical Condition Evaluation Studies, FDA Phase 2?
Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Therapy-Related Cancer ‐ Abnormal growths of tissue that follow a previous neoplasm but…
- Is, HSN Type ‐ A group of inherited disorders characterized by degeneration…
- Medical Waste Disposal ‐ Management, removal, and elimination of biologic, infectious,…
- Life Cycle Stages ‐ The continuous sequence of changes undergone by metamorphosing…
- Peripheral Nerve ‐ The nerves outside of the brain and spinal cord, including the…
- Renin-Angiotensin-Aldosterone Effects ‐ The state of the body in relation to the intake and excretion…
- Sugar Self-Monitoring, Blood ‐ Self evaluation of whole blood glucose levels outside the clinical…
- Dysgraphia ‐ Loss or impairment of the ability to write (letters, syllables,…
- Tangier Disease ‐ A rare autosomal recessive familial disorder of cholesterol metabolism,…
- SC-18862 ‐ Flavoring agent sweeter than sugar, metabolized as phenylalanine…